Search for a command to run...

Digistain uses infrared scanning to analyze cancer biopsies and generate a unique chemical fingerprint for each tumor, enabling objective prognostic scoring
Digistain uses infrared scanning to analyze cancer biopsies and generate a unique chemical fingerprint for each tumor, enabling objective prognostic scoring. This technology reduces subjective diagnostic variability that leads to unnecessary chemotherapy treatment in over 50% of breast cancer patients. By providing data-driven insights, it helps oncologists make more informed treatment decisions.
No comments yet. Be the first!
Not enough observed signals for a Pulse Index (needs 2+ signal families).
567 products launched in 2026 · 100% still active